| Phosphoproteomics |
Phosphorylation of TALIN
| C18 (+) inhibitors | Alignment / Methods |
| IMAC (+) inhibitors | Alignment / Methods |
| Site | Position | Peptide | ||
|---|---|---|---|---|
| (+) Inhib | ||||
| 5S | 2 - 7 | VALSLK | ||
| 26Y | 16 - 30 | TMQFEPSTMVYDACR | ||
| 70Y | 67 - 74 | ALDYYMLR | ||
| 78T | 75 - 82 | NGDTMEYR | ||
| 96T | 92 - 98 | MLDGTVK | ||
| 114T | 107 - 118 | TVTDMLMTICAR | ||
| 127Y | 119 - 131 | IGITNHDEYSLVR | ||
| 128S | 119 - 131 | IGITNHDEYSLVR | ||
| 144T | 138 - 146 | KEEITGTLR | ++++ | |
| 150T | 148 - 156 | DKTLLRDEK | ++++ | |
| 190T | 182 - 194 | EQGVEEHETLLLR | ||
| 311S | 307 - 316 | TYGVSFFLVK | ||
| 425S | 417 - 427 | STMLEDSVSPK | ||
| 429S-430T | 428 - 438 | K[ST]VLQQQYNR | ||
| 436Y | 428 - 438 | KSTVLQQQYNR | ||
| 446S | 442 - 454 | VEHGSVALPAIMR | ||
| 455S-458S | 455 - 482 | [SGAS]GPENFQVGSMPPAQQQITSGQMHR | ||
| 467S | 455 - 482 | SGASGPENFQVGSMPPAQQQITSGQMHR | ||
| 677S | 674 - 685 | AVASAAAALVLK | ||
| 815S | 811 - 821 | NIFSSMGDAGE | ||
| 941T | 923 - 943 | QAAASATQTIAAAQHAASTPK | ||
| 979S / 981S | 972 - 999 | GSQAQPDSPSAQLALIAASQSFLQPGGK | ||
| 1201S | 1199 - 1207 | CVSCLPGQR | ||
| 1508S | 1501 - 1510 | HTSALCNSCR | ||
| 1641S | 1639 - 1645 | TVSDSIK | ||
| 1684S | 1674 - 1690 | DLDQASLAAVSQQLAPR | ||
| 2127S | 2120 - 2130 | VMVTNVTSLLK | ||
| 2338S | 2334 - 2342 | EADESLNFE | ||
| 2530Y | 2522 - 2531 | LAQIRQQQYK | ||
| 2535S | 2532 - 2541 | FLPSELRDEH |
*Peptides detected only by
enrichment with
immobilized metal-affinity chromatography (IMAC).
# Peptides which do not require enrichment by IMAC for detection.